Close
Help




JOURNAL

Clinical Medicine Insights: Geriatrics

Eszopiclone in the Management of Insomnia Among Elderly Patients

Submit a Paper


Clinical Medicine Insights: Geriatrics 2011:4 1-8

Review

Published on 03 Feb 2011

DOI: 10.4137/CMGer.S5536


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Geriatrics

Abstract

Insomnia is an increasingly common disorder in the elderly and can have a profound, negative impact on both health and quality of life. Effective management can mitigate the adverse effects on morbidity and mortality. When possible, treatment of insomnia in the elderly should focus on conservative, non-pharmaceutical strategies and control of any potential co-morbid medical or psychiatric conditions. When needed, pharmacologic agents can be both safe and effective. Several classes are available for the treatment of insomnia. However, given their efficacy, relative safety and tolerability, non-benzodiazepines such as eszopiclone should be considered the mainstay of therapy. Eszopiclone can be a safe and effective agent for the long-term treatment of insomnia in the elderly.



Downloads

PDF  (467.54 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




Quick Links


New article and journal news notification services